Difference between revisions of "Foregut primary carcinomas"

Jump to navigation Jump to search
(→‎IHC: +HNF1-beta)
Line 18: Line 18:
*CK20 -ve.
*CK20 -ve.
*CDX2 -ve.
*CDX2 -ve.
*[[HNF-1beta]] +ve.<ref name=pmid30065837>{{cite journal |authors=Yang MX, Coates RF, Ambaye A, Gardner JA, Zubarick R, Gao Y, Skelly J, Liu JG, Mino-Kenudson M |title=Investigation of HNF-1B as a diagnostic biomarker for pancreatic ductal adenocarcinoma |journal=Biomark Res |volume=6 |issue= |pages=25 |date=2018 |pmid=30065837 |pmc=6062876 |doi=10.1186/s40364-018-0139-6 |url=}}</ref>
*[[HNF-1beta]] +ve (72-87% of cases +ve - in one study<ref name=pmid30065837>{{cite journal |authors=Yang MX, Coates RF, Ambaye A, Gardner JA, Zubarick R, Gao Y, Skelly J, Liu JG, Mino-Kenudson M |title=Investigation of HNF-1B as a diagnostic biomarker for pancreatic ductal adenocarcinoma |journal=Biomark Res |volume=6 |issue= |pages=25 |date=2018 |pmid=30065837 |pmc=6062876 |doi=10.1186/s40364-018-0139-6 |url=}}</ref>).


A (query) foregut primary panel for liver lesions:
A (query) foregut primary panel for liver lesions:
48,485

edits

Navigation menu